[go: up one dir, main page]

DE1098512B - Process for the preparation of rub-in, percutaneous effective silane esters - Google Patents

Process for the preparation of rub-in, percutaneous effective silane esters

Info

Publication number
DE1098512B
DE1098512B DESCH24171A DESC024171A DE1098512B DE 1098512 B DE1098512 B DE 1098512B DE SCH24171 A DESCH24171 A DE SCH24171A DE SC024171 A DESC024171 A DE SC024171A DE 1098512 B DE1098512 B DE 1098512B
Authority
DE
Germany
Prior art keywords
rub
percutaneous
preparation
skin
silane esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DESCH24171A
Other languages
German (de)
Inventor
Dr Friedrich Scheermesser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FRIEDRICH SCHEERMESSER DR
Original Assignee
FRIEDRICH SCHEERMESSER DR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FRIEDRICH SCHEERMESSER DR filed Critical FRIEDRICH SCHEERMESSER DR
Priority to DESCH24171A priority Critical patent/DE1098512B/en
Publication of DE1098512B publication Critical patent/DE1098512B/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896Compounds having one or more Si-O-acyl linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Description

Verfahren zur Herstellung von einreibb aren, perkutanwirks amen Silanestern Die Erfindung betrifft ein Verfahren zur Herstellung von einreibbaren, perkutanwirksamen säureabgebenden Medikamenten. Organische, die Haut nicht schädigende Säuren, z.B. Salicylsäure, dringen nach dem Auftragen auf die Haut nur in sehr geringem Maße in die Haut ein, so daß ihre medizinische Wirkung auf unter der Haut liegende Organe nur gering ist. Process for the production of rub-in, percutaneous active silane esters The invention relates to a method for the production of rub-in, percutaneous active substances acid-releasing drugs. Organic acids that do not damage the skin, e.g. Salicylic acid penetrate only to a very small extent after application to the skin into the skin, so that its medicinal effect on organs located under the skin is only slight.

Aufgabe der Erfindung ist es, die Wirkung solcher Säuren zu erhöhen, indem ihre Eindringtiefe durch die Haut hindurch vergrößert und die Eindringzeit beschleunigt wird. Erfindungsgemäß wirdDimethyldiäthoxisilan mit perkutanwirksamen, die Haut nicht schädigenden organischen Säuren verestert. Die so erhaltenen Ester dringen schnell und tief in die Haut ein, so daß die medizinische Wirkung im verstärkten Maße eintritt. The object of the invention is to increase the effect of such acids by increasing their penetration depth through the skin and increasing the penetration time is accelerated. According to the invention, dimethyl diethoxysilane is used with percutaneous, the skin is esterified with organic acids that do not damage the skin. The esters thus obtained penetrate quickly and deeply into the skin, so that the medicinal effect is enhanced Dimensions enters.

Beispiel 1 148 g Dimethyldiäthoxysilan werden mit 138 g Salicylsäure im Ölbad auf 1140C erwärmt. Nach 4 Stundeu wird die Masse auf etwa 700 C abgekühlt und etwa 1 Gewichtsprozent Wasser zugegeben. Dann wird der frei gewordene Äthylalkohol abdestilliert. Das Reaktionsprodukt wird aus warmem Alkohol umkristallisiert. Es verbleibt ein weißes kristallines Produkt von 208 g mit einem Schmelzpunkt von 158"C. Example 1 148 g of dimethyl diethoxysilane are mixed with 138 g of salicylic acid warmed to 1140C in an oil bath. After 4 hours the mass is cooled to about 700 ° C and about 1 weight percent water is added. Then the released ethyl alcohol becomes distilled off. The reaction product is recrystallized from warm alcohol. It a white crystalline product of 208 g with a melting point of 158 ° C. remains.

Beispiel 2 148 g Dimethyldiäthoxysilan werden mit 244 g Benzoesäure im Ölbad auf 134"C erwärmt. Nach 4 Stunden wird die Masse auf etwa 70"C abgekühlt und etwa 1 Gewichtsprozent Wasser zugegeben. Dann wird der frei gewordene Äthylalkohol abdestilliert. Das Reaktionsprodukt wird aus warmem Alkohol umkristallisiert. Es verbleibt ein weißes kristallines Produkt von 295 g mit einem Schmelzpunkt von 129"C. Example 2 148 g of dimethyl diethoxysilane are mixed with 244 g of benzoic acid heated in an oil bath to 134 "C. After 4 hours the mass is cooled to about 70" C. and about 1 weight percent water is added. Then the released ethyl alcohol becomes distilled off. The reaction product is recrystallized from warm alcohol. It remains a white crystalline product of 295 g with a melting point of 129 "C.

Claims (2)

PATENTANSPRUCHE 1. Verfahren zur Herstellung von einreibbaren, perkutanwirksamen Silanestern, dadurch gekennzeichnet, daß Dimethyldiäthoxysilan mit perkutanwirksamen, die Haut nicht schädigenden organischen Säuren verestert wird. PATENT CLAIMS 1. Process for the production of rub-in, percutaneous active substances Silane esters, characterized in that dimethyl diethoxysilane with percutaneous effective, organic acids that do not damage the skin are esterified. 2. Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß als perkutanwirksame Säure Salicylsäure verwendet wird. 2. The method according to claim 1, characterized in that as percutaneous effective Acid salicylic acid is used. In Betracht gezogene Druckschriften: USA.-Patentschrift Nr. 2 584341. References considered: U.S. Patent No. 2,584,341.
DESCH24171A 1958-06-02 1958-06-02 Process for the preparation of rub-in, percutaneous effective silane esters Pending DE1098512B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DESCH24171A DE1098512B (en) 1958-06-02 1958-06-02 Process for the preparation of rub-in, percutaneous effective silane esters

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESCH24171A DE1098512B (en) 1958-06-02 1958-06-02 Process for the preparation of rub-in, percutaneous effective silane esters

Publications (1)

Publication Number Publication Date
DE1098512B true DE1098512B (en) 1961-02-02

Family

ID=7429820

Family Applications (1)

Application Number Title Priority Date Filing Date
DESCH24171A Pending DE1098512B (en) 1958-06-02 1958-06-02 Process for the preparation of rub-in, percutaneous effective silane esters

Country Status (1)

Country Link
DE (1) DE1098512B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3718681A (en) * 1970-04-23 1973-02-27 Stauffer Wacker Silicone Corp Acyloxybenzoyloxysilanes
FR2615856A1 (en) * 1987-05-26 1988-12-02 Exsymol Sa New products of the condensation of silanols, their preparation and applications

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2584341A (en) * 1950-01-07 1952-02-05 Dow Corning Process of reacting an organosilane, glycerine, and glycerine-dicarboxylic acid ester

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2584341A (en) * 1950-01-07 1952-02-05 Dow Corning Process of reacting an organosilane, glycerine, and glycerine-dicarboxylic acid ester

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3718681A (en) * 1970-04-23 1973-02-27 Stauffer Wacker Silicone Corp Acyloxybenzoyloxysilanes
FR2615856A1 (en) * 1987-05-26 1988-12-02 Exsymol Sa New products of the condensation of silanols, their preparation and applications

Similar Documents

Publication Publication Date Title
DE534214C (en) Process for the production of synthetic resin from polyhydric alcohols and polybasic acids or their anhydrides
DE1234703B (en) Process for the production of optically active lactides
DE1098512B (en) Process for the preparation of rub-in, percutaneous effective silane esters
DE2004098A1 (en) Non-proede, practically partial ester-free suppository masses and processes for their production
DE649771C (en) Process for the production of purified capsaicin preparations
DE528988C (en) Process for the preparation of silicyl compounds
CH314148A (en) Process for the production of physiologically active crystallized vitamin D3 esters
DE865511C (en) Process for killing microorganisms
AT232199B (en) Process for the production of tropicalized suppository masses
DE737738C (en) Process for the preparation of basic esters
DE839937C (en) Process for the production of a benzilic acid derivative
CH253657A (en) Process for the preparation of a new derivative of a carboxylic acid.
AT51012B (en) Process for the preparation of borneol esters or borneol from pinene.
DE960896C (en) Process for the preparation of tetrahydrofurfuryl alcohol carbamic acid esters
DE583323C (en) Process for the production of high molecular weight alcohols
DE581954C (en) Process for the production of mixed esters of cellulose
DE858549C (en) Process for the production of new cellulose coils
DE567942C (en) Process for the simultaneous dissolution of rubber and nitrocellulose
DE671280C (en) Process for the production of quinine compounds with little or no taste
DE518388C (en) Process for the preparation of lactic acid esters
DE1593577A1 (en) Process for the purification of higher molecular weight esters
DE664745C (en) Process for the production of vitamin A preparations
DE937894C (en) Process for the production of Chamazulencarbonsäureestern
CH123466A (en) Process for the production of terpineol from terpineol-containing mixtures.
DE564405C (en) Process for the preparation of esters